HomeEBS • NYSE
add
Emergent Biosolutions Inc
Previous close
$9.87
Day range
$9.27 - $9.78
Year range
$1.42 - $15.10
Market cap
510.42M USD
Avg Volume
1.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 293.80M | 8.61% |
Operating expense | 92.20M | -3.96% |
Net income | 114.80M | 143.58% |
Net profit margin | 39.07 | 140.12% |
Earnings per share | 1.37 | — |
EBITDA | 97.70M | 319.31% |
Effective tax rate | 19.38% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 149.90M | 70.73% |
Total assets | 1.48B | -21.94% |
Total liabilities | 969.40M | -18.94% |
Total equity | 508.40M | — |
Shares outstanding | 54.18M | — |
Price to book | 1.05 | — |
Return on assets | 12.03% | — |
Return on capital | 14.71% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 114.80M | 143.58% |
Cash from operations | 153.70M | 156.17% |
Cash from investing | 112.00M | 692.59% |
Cash from financing | -180.30M | -319.30% |
Net change in cash | 85.40M | 10,775.00% |
Free cash flow | 154.31M | 111.86% |
About
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Founded
Sep 5, 1998
Headquarters
Website
Employees
1,600